876 related articles for article (PubMed ID: 3795042)
1. Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries.
Hondeghem LM; Ayad MJ; Robertson RM
J Pharmacol Exp Ther; 1986 Dec; 239(3):808-13. PubMed ID: 3795042
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
[TBL] [Abstract][Full Text] [Related]
3. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
[TBL] [Abstract][Full Text] [Related]
4. Effects of nitrendipine (BAY e 5009), nifedipine, verapamil, phentolamine, papaverine, and minoxidil on contractions of isolated rabbit aortic smooth muscle.
Towart R
J Cardiovasc Pharmacol; 1982; 4(6):895-902. PubMed ID: 6185780
[TBL] [Abstract][Full Text] [Related]
5. Vasodilator mechanism of KB-944, a new calcium antagonist.
Morita T; Kanazawa T; Ito K; Nose T
Arzneimittelforschung; 1982; 32(9):1043-6. PubMed ID: 6890823
[TBL] [Abstract][Full Text] [Related]
6. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
[TBL] [Abstract][Full Text] [Related]
7. Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery.
Noguera I; Medina P; Segarra G; Martínez MC; Aldasoro M; Vila JM; Lluch S
Br J Pharmacol; 1997 Oct; 122(3):431-8. PubMed ID: 9351498
[TBL] [Abstract][Full Text] [Related]
8. Slow channel calcium blockers attenuate reoxygenation-mediated vascular contraction, but augment anoxia-mediated vascular contraction.
Haught WH; Yang BC; Lawson DL; Mehta JL
J Cardiovasc Pharmacol; 1992 May; 19(5):701-8. PubMed ID: 1381767
[TBL] [Abstract][Full Text] [Related]
9. Effect of diltiazem on calcium- and noradrenaline-induced contractions in isolated rabbit aorta.
Nagao T; Ikeo T; Sato M; Nakajima H; Kiyomoto A
Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 11():437-40. PubMed ID: 1031941
[TBL] [Abstract][Full Text] [Related]
10. Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta.
Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1991; 312():86-103. PubMed ID: 1663336
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of inhibitory action of diltiazem on vascular smooth muscle contractility.
van Breemen C; Hwang O; Meisheri KD
J Pharmacol Exp Ther; 1981 Aug; 218(2):459-63. PubMed ID: 7252845
[TBL] [Abstract][Full Text] [Related]
12. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
Nishimura K; Miyawaki N; Yamauchi H; Iso T
Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
14. Effects of Ca antagonists on Ca fluxes in resistance vessels.
Cauvin C; Saida K; van Breemen C
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S287-90. PubMed ID: 6184554
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of various L-type and T-type calcium antagonists on electrically generated, potassium-induced and carbachol-induced contractions of porcine detrusor muscle.
Badawi JK; Li H; Langbein S; Kamp S; Guzman S; Bross S
J Comp Physiol B; 2006 Jun; 176(5):429-39. PubMed ID: 16425017
[TBL] [Abstract][Full Text] [Related]
16. [Different sites of action of diltiazem, nifedipine and verapamil on the myocardium and aortic and coronary smooth muscles].
Raddino R; Poli E; Manca C; Ceconi C; Ferrari R
Cardiologia; 1986 Jan; 31(1):47-53. PubMed ID: 3742515
[No Abstract] [Full Text] [Related]
17. Differential sensitivity to calcium entry blockade of angiotensin II-induced contractions of rat and guinea-pig aorta.
van Heiningen PN; van Zwieten PA
Arch Int Pharmacodyn Ther; 1988; 296():118-30. PubMed ID: 3240015
[TBL] [Abstract][Full Text] [Related]
18. Effects of a novel calcium channel agonist dihydropyridine analogue, Bay k 8644, on pig coronary artery: biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine.
Dubé GP; Baik YH; Schwartz A
J Cardiovasc Pharmacol; 1985; 7(2):377-89. PubMed ID: 2581094
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibitory action of Biginelli-type dihydropyrimidines on depolarization-induced arterial smooth muscle contraction.
Cernecka H; Veizerova L; Mensikova L; Svetlik J; Krenek P
J Pharm Pharmacol; 2012 May; 64(5):735-41. PubMed ID: 22471370
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of inhibitory action of sodium nitroprusside in vascular smooth muscle of rabbit aorta.
Karaki H; Murakami K; Urakawa N
Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):230-40. PubMed ID: 3718086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
